ATC code - N06DA03
PolandRivastigmine
-
Form: plaster, transdermal system
Active substance Dosage rivastigmine 4.6 mg/24 h ATC code: N06DA03
Manufacturer: Luye Pharma AG
-
Form: plaster, transdermal system
Active substance Dosage rivastigmine 9.5 mg/24 h ATC code: N06DA03
Manufacturer: Luye Pharma AG
-
Form: plaster, transdermal system
Active substance Dosage rivastigmine 9.5 mg/24 h ATC code: N06DA03
Manufacturer: Zentiva, joint-stock company
-
Form: plaster, transdermal system
Active substance Dosage rivastigmine 19.2 mg ATC code: N06DA03
Manufacturer: Luye Pharma AG Zentiva SA
-
Form: plaster, transdermal system
ATC code: N06DA03
Manufacturer: Zentiva, joint-stock company
-
Form: capsules, hard
Active substance Dosage rivastigmine hydrogen tartrate 2.4 mg ATC code: N06DA03
Manufacturer: Bausch Health Poland Sp. z o.o.
-
Form: capsules, hard
Active substance Dosage rivastigmine hydrogen tartrate 4.8 mg ATC code: N06DA03
Manufacturer: Bausch Health Poland Sp. z o.o.
-
Form: capsules, hard
Active substance Dosage rivastigmine hydrogen tartrate 7.2 mg ATC code: N06DA03
Manufacturer: Bausch Health Poland Sp. z o.o.
-
Form: capsules, hard
Active substance Dosage rivastigmine hydrogen tartrate 9.6 mg ATC code: N06DA03
Manufacturer: Bausch Health Poland Sp. z o.o.
-
Form: capsules, hard
Active substance Dosage rivastigmine 1.5 mg ATC code: N06DA03
Manufacturer: Adamed Pharma S.A.
-
Form: capsules, hard
Active substance Dosage rivastigmine 3 mg ATC code: N06DA03
Manufacturer: Adamed Pharma S.A.
-
Form: capsules, hard
Active substance Dosage rivastigmine 4.5 mg ATC code: N06DA03
Manufacturer: Adamed Pharma S.A.
-
Form: capsules, hard
Active substance Dosage rivastigmine 6 mg ATC code: N06DA03
Manufacturer: Adamed Pharma S.A.
-
Form: plaster, transdermal system
Active substance Dosage rivastigmine 6.9 mg ATC code: N06DA03
Manufacturer: Luye Pharma AG
-
Form: plaster, transdermal system
Active substance Dosage rivastigmine 13.8 mg ATC code: N06DA03
Manufacturer: Luye Pharma AG
-
Form: capsules, hard
Active substance Dosage rivastigmine hydrogen tartrate 2.4 mg ATC code: N06DA03
Manufacturer: Genepharm S.A. neuraxpharm Arzneimittel GmbH
-
Form: capsules, hard
Active substance Dosage rivastigmine hydrogen tartrate 4.8 mg ATC code: N06DA03
Manufacturer: Genepharm S.A. neuraxpharm Arzneimittel GmbH
-
Form: capsules, hard
Active substance Dosage rivastigmine hydrogen tartrate 7.2 mg ATC code: N06DA03
Manufacturer: Genepharm S.A. neuraxpharm Arzneimittel GmbH
-
Form: capsules, hard
Active substance Dosage rivastigmine hydrogen tartrate 9.6 mg ATC code: N06DA03
Manufacturer: Genepharm S.A. neuraxpharm Arzneimittel GmbH
-
Form: capsules, hard
Active substance Dosage rivastigmine hydrogen tartrate 2.4 mg ATC code: N06DA03
Manufacturer: Orion Corporation Orion Pharma
-
Form: capsules, hard
Active substance Dosage rivastigmine hydrogen tartrate 4.8 mg ATC code: N06DA03
Manufacturer: Orion Corporation Orion Pharma
-
Form: capsules, hard
Active substance Dosage rivastigmine hydrogen tartrate 7.2 mg ATC code: N06DA03
Manufacturer: Orion Corporation Orion Pharma
-
Form: capsules, hard
Active substance Dosage rivastigmine hydrogen tartrate 9.6 mg ATC code: N06DA03
Manufacturer: Orion Corporation Orion Pharma